Epithelial to Mesenchymal Markers from from Atlas Antibodies

The EMT Marker Panel consists of PrecisA mouse monoclonal antibodies targeting key proteins involved in epithelial to mesenchymal transition. The antibodies are developed and rigorously validated using both WB analysis and IHC in normal and cancerous human tissues.

All antibodies are approved for IHC application and the vast majority for Western Blot. All panel members belong to the PrecisA Monoclonals brand and have been developed under the same stringent conditions, ensuring secured continuity and stable supply.